Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii (Q33934704)

30 July 2017

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii (English)

1 reference

30 July 2017

Acinetobacter baumannii

1 reference

1 reference

Michael J McConnell

1

1 reference

30 July 2017

Carlos Rumbo

series ordinal

2

1 reference

30 July 2017

Germán Bou

series ordinal

3

1 reference

30 July 2017

Jerónimo Pachón

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 June 2011

1 reference

30 July 2017

1 reference

30 July 2017

29

1 reference

30 July 2017

34

1 reference

30 July 2017

5705-5710

1 reference

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Biological functions and biogenesis of secreted bacterial outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Bacterial outer membrane vesicles and the host-pathogen interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Membrane vesicles traffic signals and facilitate group activities in a prokaryote

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.001

10.1016/J.VACCINE.2011.06.001

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference